KEGG pathway analysis revealed that JSK might produce anti-SCI effects via multiple signaling pathways, including those in cancer, and the TNF, HIF-1, Toll-like receptor, and PI3K-Akt signaling pathways. This evidence concerns the gene AKT1 and cancer.